Shiva Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.27 Cr
as on 17-07-2024
- Company Age 22 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.36 Cr
as on 17-07-2024
- Satisfied Charges ₹ 1.92 Cr
as on 17-07-2024
- Revenue 5.96%
(FY 2022)
- Profit -32.03%
(FY 2022)
- Ebitda 2.55%
(FY 2022)
- Net Worth 216.04%
(FY 2022)
- Total Assets 71.43%
(FY 2022)
About Shiva Laboratories
The Corporate was formerly known as Window Pharmaceuticals Private Limited. The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.27 Cr.
The company currently has active open charges totaling ₹4.36 Cr. The company has closed loans amounting to ₹1.92 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajeev Kumar and Vinod Singh serve as directors at the Company.
- CIN/LLPIN
U24230BR2002PTC009895
- Company No.
009895
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shiva Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Singh  | Managing Director | 29-Jan-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajeev Kumar | Director | 29-Aug-2011 | Current |
Financial Performance and Corporate Structure Insights of Shiva Laboratories.
Shiva Laboratories Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.96% increase. The company also saw a substantial fall in profitability, with a 32.03% decrease in profit. The company's net worth Soared by an impressive increase of 216.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shiva Laboratories?
In 2021, Shiva Laboratories had a promoter holding of 36.69% and a public holding of 63.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Aug 2023 | ₹2.08 Cr | Open |
State Bank Of India Creation Date: 10 May 2019 | ₹2.28 Cr | Open |
State Bank Of India Creation Date: 28 Apr 2012 | ₹1.92 Cr | Satisfied |
How Many Employees Work at Shiva Laboratories?
Unlock and access historical data on people associated with Shiva Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Apr 02, 2021, Shiva Laboratories has raised a total of ₹ 2.28 Cr, with the most recent deal valued at ₹ 2.7 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
